281
Louis Kyron, CPA, CGA
Editor in Chief @LouisKyron
The content are opinions only and are not intended as investment advice or any buy/sell recommendation but rather for education and awareness purposes only. Always seek out a professional Financial or Investment Advisor for advice and information as warranted
Is BLVG a present waiting to be unwrapped? YOU DECIDE.
It is not very often I write a case study on our cover feature company; however, HUGE warrants some quick hits. Your case study this month is to use the entire content in this issue as well as information available on their website and other reputable sources to determine
if FSD Pharma
may have a
place in your
own portfolio.
These are just
some quick hits.
HUGE has
three facilities:
1. Cobourg Ontario - has the potential to host over 3,800,000 sq. ft. of cultivation and processing area. Through this, FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.
2. Montreal Quebec – Cannara Biotech. HUGE owns approximately
25%. for
the
purpose of
cultivating
and/or
selling
cannabis
and
cannabis-
derived products. At this time, FSD Pharma and Cannara Biotech have a combined floor space of over 1.245 million square feet of indoor growing capacity.
3. Newfoundland and Labrador – purchased 51% of Atlantic Island Cannabis Inc (to be renamed FSD Atlantic Pharma Inc). formed to build a solid platform for locally driven economic opportunities and sustained progress in the province of Newfoundland & Labrador. ATLC has been working with the province for the supply agreement and retail licenses. As an organization, ATLC believes in building strategic partnerships and focused investments to create jobs and local employment avenues.
Recent Highlights.
FSD Pharma Inc.
CSE:HUGE
As At: November 30, 2018
Net Shares Outstanding: 1,319,600,458
Share Price: $0.395
Market Cap: $ 521,242,181
Website: http://fsdpharma.com/
305